Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A project aimed at tackling heart failure led by Associate Professor Sarah De Val is to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year.

Nearly a million people in the UK are living with heart failure, often a long-term consequence of damage caused by a heart attack. After a heart attack, the heart often fails to form adequate new blood vessels to fully heal. Associate Professor Sarah De Val and Dr Alice Neal have been studying the pathways regulating the formation and differentiation of vein and lymphatic vessels both in development and after a heart attack or other tissue damage. Not only are venous and lymphatic endothelial cells crucial for the correct function of the circulatory system, they can also be used as building blocks for other types of vessels.

The De Val Group’s research focuses on the study of enhancers, the on-off switches of genes, in order to identify which proteins activate the correct pattern of blood and lymphatic vessel growth during tissue repair. As part of this research, they have described multiple regulatory pathways responsible for the different aspects of blood vessels formation in the developing heart. In doing so they identified a crucial pathway that is repressed in the adult heart after injury.

 

“In the damaged neonatal heart, which can regenerate, we have evidence that this pathway reactivates as expected, yet the adult heart seems to be inadvertently repressing it. So, we’re trying to persuade the recalcitrant adult heart to better activate this pathway and hopefully therefore grow more of the right type of new vessels. - Professor Sarah De Val

Since it is now clear that most new vessels originate from vein endothelial cells, the De Val lab has also been very interested in how veins are formed, and how some of them know to turn into arterial cells. This is particularly important in the context of a heart attack, which is usually caused by a blockage in the left descending aorta. Some people do not have a heart attack when this region of the aorta becomes blocked because they have collateral arteries, which are direct connections between two arteries.

 

If we can understand how these specialised arteries are formed, and if we can get people to make them, you could not only improve blood supply after a heart attack, but potentially stop them from having heart attacks in the first place. - Professor Sarah De Val

Dr Alice Neal will be one of three researchers running as part of the BHF team, alongside patients and relatives who have benefitted from BHF research.

 

The BHF is our major funder. Without the BHF, a lot of this science simply wouldn't be happening. - Dr Alice Neal

Visit the Department of Physiology, Anatomy and Genetics website for the full story.

Similar stories

Ludwig Oxford retreat 2022 – a recap

On 13-14th June 2022, the Oxford Branch of the Ludwig Institute for Cancer Research held their annual retreat to discuss key scientific advances within the Branch and beyond.

Ludwig Oxford team completes the BHF London to Brighton Bike ride

On Sunday 19th June, the Ludwig Oxford team took on the London to Brighton cycle challenge to help raise more than £2.8 million for the British Heart Foundation.